Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Aryl hydrocarbon receptor and kynurenine: recent advances in autoimmune disease research.
Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis.
Microglia: Multitasking Specialists of the Brain.
Comparing voice self-assessment with auditory perceptual analysis in patients with multiple sclerosis.
'You are just left to get on with it': qualitative study of patient and carer experiences of the transition to secondary progressive multiple sclerosis.
The Incidence and Prevalence of Thyroid Disease Do Not Differ in the Multiple Sclerosis and General Populations: A Validation Study Using Administrative Data.
Complement-dependent pathogenicity of brain-specific antibodies in cerebrospinal fluid.
Cutting Edge: CD99 Is a Novel Therapeutic Target for Control of T Cell-Mediated Central Nervous System Autoimmune Disease.
Sequencing the immunopathologic heterogeneity in multiple sclerosis.
B cells assume the command.
Dalfampridine: review of its efficacy in improving gait in patients with multiple sclerosis.
Adrenomedullin protects from experimental autoimmune encephalomyelitis at multiple levels.
Sera from patients with seropositive neuromyelitis optica spectral disorders caused the degeneration of rodent optic nerve.
Systematic Review and meta-analysis of the Efficacy of sphingosine-1-phosphate (S1P) receptor agonist FTY720 (fingolimod) in Animal Models of Stroke.
Magnetic resonance imaging reveals therapeutic effects of interferon-beta on cytokine-induced reactivation of rat model of multiple sclerosis.
Cesarean section and offspring's risk of multiple sclerosis: a Danish nationwide cohort study.
Regional regulation of glutamate signaling during cuprizone-induced demyelination in the brain.
Estimated Prevalence and Incidence of Multiple Sclerosis in Iran.
Treatment of mood disorders in multiple sclerosis.
Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine.
Incorporating covariates in skewed functional data models.
[Progressive multifocal leukoencephalopathy associated to natalizumab: the importance of magnetic resonance imaging in its early diagnosis].
Comparative efficacy of alemtuzumab and established treatment in the management of multiple sclerosis.
Glatiramer acetate-induced hepatitis in a patient with multiple sclerosis.
Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial.
Pages
« first
‹ previous
…
514
515
516
517
518
519
520
521
522
…
next ›
last »